Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%.

Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Roszko P, Zegarelli E, Wood CC.

J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1128-32.

PMID:
7751529
2.

Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.

Dockhorn R, Aaronson D, Bronsky E, Chervinsky P, Cohen R, Ehtessabian R, Finn A, Grossman J, Howland W, Kaiser H, Pearlman D, Sublett J, Ratner P, Settipane G, Sim T, Storms W, Webb R, Drda K, Wood C.

Ann Allergy Asthma Immunol. 1999 Apr;82(4):349-59.

PMID:
10227333
3.

Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.

Georgitis JW, Banov C, Boggs PB, Dockhorn R, Grossman J, Tinkelman D, Roszko P, Wood C.

Clin Exp Allergy. 1994 Nov;24(11):1049-55.

PMID:
7874603
4.

Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial.

Finn AF Jr, Aaronson D, Korenblat P, Lumry W, Settipane G, Spector S, Woehler T, Drda K, Wood CC.

Am J Rhinol. 1998 Nov-Dec;12(6):441-9.

PMID:
9883302
5.

Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology.

Meltzer EO, Orgel HA, Bronsky EA, Findlay SR, Georgitis JW, Grossman J, Ratner P, Wood CC.

J Allergy Clin Immunol. 1992 Aug;90(2):242-9.

PMID:
1386857
6.

A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.

Bronsky EA, Druce H, Findlay SR, Hampel FC, Kaiser H, Ratner P, Valentine MD, Wood CC.

J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1117-22.

PMID:
7751528
7.

Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications.

Grossman J, Banov C, Boggs P, Bronsky EA, Dockhorn RJ, Druce H, Findlay SR, Georgitis JW, Hampel FC, Kaiser H, et al.

J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1123-7.

PMID:
7538520
8.

Ipratropium nasal spray in children with perennial rhinitis.

Meltzer EO, Orgel HA, Biondi R, Georgitis J, Milgrom H, Munk Z, Van Bavel J, Wood CC, Drda K.

Ann Allergy Asthma Immunol. 1997 May;78(5):485-91.

PMID:
9164362
9.

Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies.

Kim KT, Kerwin E, Landwehr L, Bernstein JA, Bruner D, Harris D, Drda K, Wanger J, Wood CC; Pediatric Atrovent Nasal Spray Study Group.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):73-9.

PMID:
15702820
10.

Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine.

Baroody FM, Majchel AM, Roecker MM, Roszko PJ, Zegarelli EC, Wood CC, Naclerio RM.

J Allergy Clin Immunol. 1992 Jun;89(6):1065-75.

PMID:
1535082
11.

A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold.

Diamond L, Dockhorn RJ, Grossman J, Kisicki JC, Posner M, Zinny MA, Koker P, Korts D, Wecker MT.

J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1139-46.

PMID:
7751531
12.

Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.

Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT.

Ann Intern Med. 1996 Jul 15;125(2):89-97.

PMID:
8678385
13.

Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions.

Wagenmann M, Baroody FM, Jankowski R, Nadal JC, Roecker-Cooper M, Wood CC, Naclerio RM.

Clin Exp Allergy. 1994 Mar;24(3):288-90.

PMID:
8012861
14.

The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis.

Kaiser HB, Findlay SR, Georgitis JW, Grossman J, Ratner PH, Tinkelman DG, Wood CC.

Allergy Asthma Proc. 1998 Jan-Feb;19(1):23-9.

PMID:
9532321
15.

Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis.

Druce HM, Spector SL, Fireman P, Kaiser H, Meltzer EO, Boggs P, Wood CC, Paluch EP.

Ann Allergy. 1992 Jul;69(1):53-60.

PMID:
1385682
16.

Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children.

Milgrom H, Biondi R, Georgitis JW, Meltzer EO, Munk ZM, Drda K, Wood CC.

Ann Allergy Asthma Immunol. 1999 Aug;83(2):105-11.

PMID:
10480582
17.
18.

Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide.

Dolovich J, Kennedy L, Vickerson F, Kazim F.

J Allergy Clin Immunol. 1987 Sep;80(3 Pt 1):274-8.

PMID:
2957416
19.

Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. An open follow-up study of efficacy and safety.

Schultz Larsen F, Mygind N, Larsen FS.

Clin Otolaryngol Allied Sci. 1983 Aug;8(4):267-72.

PMID:
6228346
20.

The anticholinergic treatment of allergic perennial rhinitis.

Georgitis JW.

J Allergy Clin Immunol. 1992 Dec;90(6 Pt 2):1071-6.

PMID:
1460210

Supplemental Content

Support Center